Charles Glommen Joins CureMatch as Chief Technology Officer
CureMatch, Inc., a leader in precision medicine digital decision support solutions for oncology, today welcomes the arrival of Charles Glommen as chief technology officer, to support the company’s further development of artificial intelligence (AI)-based solutions for precision cancer treatment.
Glommen, a respected technology leader and startup founder in the San Diego region, brings more than twenty years of software architecture and engineering experience to the CureMatch executive team. Throughout his career, he has helped build and transform ….Read More